COVID exposed a diagnostic-data problem
During the pandemic, diagnostic testing moved rapidly beyond traditional laboratories into homes, pharmacies, workplaces, schools, community sites, and temporary locations. That expanded access, but many results generated outside conventional laboratory systems were difficult to capture and transmit in a standardized, timely way.
The test became decentralized. The data infrastructure did not.
FDA created an initiative to address the gap
FDA's Digital Diagnostics program identifies SAFE Health Systems as the awardee contracted to lead the Open Connected Diagnostics initiative. FDA describes the work as an effort to accelerate connected-diagnostics capabilities for use with digital health platforms in clinical workflows.
The published objectives include methods and standards-based technologies for OTC and point-of-care data capture, an interoperability specification and developer toolset, and a reference implementation with pilot programs. These are initiative objectives; they should not be read as a blanket claim that every component is complete, universally adopted, or FDA endorsed for a particular commercial use.
Thousands of tests, one healthcare ecosystem
Diagnostic manufacturers naturally design products around their own technologies. One test may use a smartphone camera, another NFC or Bluetooth, and another a dedicated reader.
Without shared specifications, each product can become another proprietary integration. Healthcare needs a way to transform heterogeneous outputs into consistent, usable information without erasing device-specific provenance.
Open technologies instead of another closed platform
FDA says the initiative aims to establish interoperable connections between point-of-need diagnostic data silos. Its program description calls for:
- a standards-based interoperability specification
- developer tools for embedding connected-diagnostics capabilities
- a reference implementation
- pilots that demonstrate capture, harmonization, transmission, and downstream utility
The goal is reusable infrastructure that manufacturers and developers can implement—not a single proprietary consumer application.
A common diagnostic data model
A connected diagnostic workflow needs to answer basic questions consistently:
- What test was performed and which product generated it?
- Who or what captured the result, and when?
- What specimen and method were used?
- What was the value, unit, interpretation, and reference context?
- How should the concept be represented and where may it be transmitted?
Standardization makes those facts machine-readable and preserves provenance.
That record can participate in EHR workflows, telehealth, longitudinal records, public-health reporting, analytics, research, and governed clinical decision support when the applicable permissions and requirements are met.
Healthcare standards provide the bridge
Connected diagnostic information may use standards such as FHIR for exchange, LOINC for test identification, UCUM for quantitative units, SNOMED CT for applicable qualitative results or specimen concepts, and structured device identifiers and metadata.
Terminology alone is not sufficient. Correct interpretation also depends on the result value, units, reference range, specimen, method, device, timestamps, and context.
Open infrastructure can reduce duplicated integration work
Without a shared framework, every diagnostic company may need to independently build mobile connectivity, result normalization, EHR interfaces, public-health interfaces, developer APIs, and clinical integrations. Application developers then need to interpret every proprietary protocol.
An open framework can reduce duplicated work while allowing manufacturers to retain product-specific innovation and applications to consume normalized representations.
From OpenCDx principles to deployable workflows
HealthCheck positions SafeCDx as a platform for operationalizing connected-diagnostic workflows, including product onboarding, test identity and activation, guided use, result capture, provenance, normalization, clinical routing, interoperability, and reporting.
This is HealthCheck's product positioning, distinct from FDA's description of the Open Connected Diagnostics initiative. Specific capabilities, integrations, and regulatory status should be substantiated for each deployment.
Why open standards matter for AI and public health
AI systems cannot reliably reason across diagnostic information if each device represents the same clinical concept differently. Normalization can provide governed, structured context while preserving the original evidence.
At population scale, authorized and privacy-governed diagnostic data may also support surveillance, geographic trend detection, product-performance monitoring, and emergency response. Those uses require purpose limitation, data minimization, security, governance, and applicable public-health authority.
The infrastructure lesson
The future diagnostic ecosystem will include many manufacturers, technologies, modalities, and testing environments. No single proprietary application should be the universal answer.
The scalable model is open standards at the interoperability layer and competitive innovation at the product and application layers. Open Connected Diagnostics is significant because it seeks to make distributed diagnostic information part of the broader healthcare data ecosystem—not merely connect a test to a phone.
Primary sources
- 1.Digital Diagnostics: OTC and Point-of-Care — U.S. Food and Drug Administration. Accessed 2026-08-24.
- 2.Representing Laboratory Result Values — ASTP/Office of the National Coordinator for Health IT. Accessed 2026-08-24.